BROLUCIZUMAB

BROLUCIZUMAB was reported 3648 times

BROLUCIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CORNEAL EPITHELIAL DOWNGROWTH 1 1.0000
1 RETINAL PERIVASCULAR SHEATHING 74 0.7184
2 TRANSILLUMINATION 1 0.5000
3 KERATIC PRECIPITATES 217 0.4568
4 VISUAL ACUITY TESTS 3 0.4286
5 ANTERIOR CHAMBER CELL 233 0.3263
6 RETINAL VASCULITIS 384 0.3224
7 ANTERIOR CHAMBER FLARE 73 0.3133
8 VITREOUS HAZE 47 0.3072
9 VITREAL CELLS 60 0.2970
10 VITREOUS OPACITIES 223 0.2639
11 IRIDODONESIS 1 0.2500
12 CILIARY BODY HAEMORRHAGE 1 0.2500
13 IDIOPATHIC ORBITAL INFLAMMATION 42 0.2188
14 INTRA-OCULAR INJECTION COMPLICATION 48 0.2115
15 ANTERIOR CHAMBER INFLAMMATION 120 0.2017
16 CHOLESTEROLOSIS BULBI 1 0.2000
17 VITRITIS 358 0.1932
18 RETINAL OCCLUSIVE VASCULITIS 43 0.1920
19 SUBRETINAL FLUID 204 0.1866
20 SUBRETINAL HYPERREFLECTIVE EXUDATION 5 0.1852
21 OPHTHALMOLOGICAL EXAMINATION 2 0.1667
22 VITREOUS HAEMATOMA 1 0.1667
23 RETINAL VASCULAR OCCLUSION 122 0.1649
24 VISUAL ACUITY REDUCED TRANSIENTLY 48 0.1558
25 POSTERIOR SEGMENT OF EYE ANOMALY 1 0.1429
26 ANTERIOR CHAMBER OPACITY 2 0.1429
27 DENNIE-MORGAN FOLD 1 0.1429
28 FOVEAL DEGENERATION 3 0.1304
29 OCULAR VASCULITIS 21 0.1214
30 RETINAL INFILTRATES 7 0.1148
31 EPISCLERAL HYPERAEMIA 1 0.1111
32 CHOROIDAL SCLEROSIS 1 0.1111
33 VITREOUS FIBRIN 3 0.1071
34 CHOROIDAL RUPTURE 2 0.1053
35 RETINAL DRUSEN 16 0.0976
36 PITTED KERATOLYSIS 1 0.0909
37 VITREOUS ABSCESS 1 0.0909
38 MACULAR OPACITY 2 0.0909
39 WHITE BLOOD CELL AGGLUTINATION PRESENT 1 0.0833
40 RETINAL ARTERY STENOSIS 3 0.0833
41 CYCLITIS 3 0.0811
42 RETINAL ISCHAEMIA 47 0.0769
43 ERYTHROBLAST COUNT ABNORMAL 1 0.0769
44 BULLOUS KERATOPATHY 1 0.0714
45 ANTERIOR CHAMBER FIBRIN 9 0.0698
46 CHORIORETINITIS 45 0.0698
47 IRIS VASCULAR DISORDER 1 0.0667
48 VITREORETINAL TRACTION SYNDROME 6 0.0632
49 ORBITAL SPACE OCCUPYING LESION 1 0.0625
50 RETINAL ARTERY OCCLUSION 156 0.0617
51 RETINAL OEDEMA 115 0.0601
52 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 53 0.0596
53 FOVEAL REFLEX ABNORMAL 1 0.0588
54 CENTRAL VISION LOSS 13 0.0583
55 RETINAL EXUDATES 54 0.0577
56 VITREOUS FLOATERS 558 0.0567
57 SUBRETINAL FIBROSIS 11 0.0564
58 PAPILLOPHLEBITIS 1 0.0556
59 KERATOUVEITIS 2 0.0541
60 PSEUDOXANTHOMA ELASTICUM 1 0.0526
61 OPHTHALMIC ARTERY THROMBOSIS 1 0.0526
62 CILIARY HYPERAEMIA 5 0.0526
63 OPTIC DISC VASCULAR DISORDER 1 0.0526
64 CHOROIDAL NEOVASCULARISATION 45 0.0524
65 ANTERIOR CHAMBER DISORDER 12 0.0522
66 CORNEAL ENDOTHELIITIS 5 0.0521
67 ANTERIOR CHAMBER PIGMENTATION 1 0.0500
68 IRIDOCYCLITIS 157 0.0496
69 FUNDOSCOPY ABNORMAL 5 0.0481
70 IRITIS 145 0.0477
71 VITREOUS DISORDER 23 0.0476
72 EYE INFLAMMATION 447 0.0468
73 NON-INFECTIOUS ENDOPHTHALMITIS 38 0.0448
74 SUBRETINAL HAEMATOMA 2 0.0444
75 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 62 0.0443
76 RETINAL NEOVASCULARISATION 11 0.0437
77 EYE OPACITY 4 0.0435
78 CORNEAL GRAFT FAILURE 1 0.0435
79 LENTICULAR PIGMENTATION 1 0.0417
80 RETINAL FIBROSIS 3 0.0417
81 SUBCLAVIAN VEIN OCCLUSION 1 0.0417
82 VITREOUS PROLAPSE 1 0.0417
83 METAMORPHOPSIA 75 0.0407
84 PERIPHLEBITIS 3 0.0405
85 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 2 0.0385
86 HYPOPYON 30 0.0362
87 RETINAL CYST 6 0.0361
88 RETINAL DEPIGMENTATION 11 0.0359
89 PAPILLITIS 6 0.0357
90 MACULAR PIGMENTATION 3 0.0357
91 EXFOLIATION GLAUCOMA 1 0.0357
92 RETINAL ANEURYSM 7 0.0350
93 RETINAL VASCULAR DISORDER 20 0.0342
94 ANGIOSCLEROSIS 2 0.0333
95 CHOROIDAL INFARCTION 4 0.0333
96 NONINFECTIVE CHORIORETINITIS 1 0.0333
97 ARTERIOSCLEROTIC RETINOPATHY 3 0.0330
98 PANOPHTHALMITIS 6 0.0328
99 POLYPOIDAL CHOROIDAL VASCULOPATHY 10 0.0323
100 MACULAR DYSTROPHY CONGENITAL 1 0.0323
101 CONJUNCTIVOCHALASIS 1 0.0323
102 POSTERIOR CAPSULE OPACIFICATION 11 0.0321
103 IRIS NEOVASCULARISATION 4 0.0320
104 VESSEL PUNCTURE SITE INJURY 1 0.0312
105 MACULAR TELANGIECTASIA 1 0.0303
106 EYELID CONTUSION 2 0.0299
107 VITAL DYE STAINING CORNEA PRESENT 1 0.0294
108 RETINAL SCAR 13 0.0282
109 CORNEAL STRIAE 2 0.0282
110 MACULAR RUPTURE 1 0.0278
111 UVEITIS 364 0.0268
112 CONJUNCTIVAL SCAR 4 0.0265
113 UVEITIC GLAUCOMA 1 0.0263
114 RETINAL DEPOSITS 5 0.0246
115 RETINAL DEGENERATION 32 0.0246
116 OPTIC NERVE SHEATH HAEMORRHAGE 2 0.0244
117 AGE-RELATED MACULAR DEGENERATION 37 0.0244
118 AUTOIMMUNE EYE DISORDER 1 0.0238
119 RETINAL ARTERY EMBOLISM 5 0.0238
120 SUPRANUCLEAR PALSY 1 0.0238
121 IRIS ADHESIONS 12 0.0234
122 NEOVASCULARISATION 6 0.0228
123 OPTIC DISC HAEMORRHAGE 5 0.0218
124 PH BODY FLUID DECREASED 1 0.0217
125 EPIRETINAL MEMBRANE 6 0.0216
126 APHAKIA 1 0.0213
127 PERIORBITAL ABSCESS 1 0.0208
128 LENTICULAR OPACITIES 9 0.0206
129 NARROW ANTERIOR CHAMBER ANGLE 2 0.0204
130 PSEUDOENDOPHTHALMITIS 2 0.0202
131 EYE INFARCTION 2 0.0200
132 INTRAOCULAR HAEMATOMA 1 0.0200
133 RETINAL HAEMORRHAGE 135 0.0189
134 OPTIC PERINEURITIS 1 0.0185
135 VITREOUS DEGENERATION 3 0.0183
136 TRACTIONAL RETINAL DETACHMENT 2 0.0180
137 VASCULAR WALL HYPERTROPHY 1 0.0179
138 CORTICAL VISUAL IMPAIRMENT 1 0.0172
139 HYPHAEMA 9 0.0172
140 OPHTHALMIC ARTERY OCCLUSION 1 0.0172
141 CORNEAL LEUKOMA 1 0.0167
142 ARCUS LIPOIDES 1 0.0159
143 RETINAL PIGMENT EPITHELIAL TEAR 11 0.0159
144 OPTIC DISCS BLURRED 1 0.0156
145 VITREOUS HAEMORRHAGE 43 0.0155
146 CHOROIDAL HAEMORRHAGE 3 0.0155
147 OCULAR PROCEDURAL COMPLICATION 3 0.0155
148 DYSMETROPSIA 1 0.0154
149 HAEMORRHAGIC VASCULITIS 2 0.0153
150 CATARACT NUCLEAR 10 0.0150
151 RETINAL THICKENING 25 0.0150
152 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
153 RETINAL VEIN OCCLUSION 42 0.0146
154 CHORIORETINAL ATROPHY 3 0.0145
155 PRESBYOPIA 8 0.0144
156 DRY AGE-RELATED MACULAR DEGENERATION 16 0.0144
157 VISUAL ACUITY TESTS ABNORMAL 8 0.0144
158 BLINDNESS TRANSIENT 106 0.0144
159 SUDDEN VISUAL LOSS 4 0.0143
160 SEROUS RETINAL DETACHMENT 12 0.0143
161 OPTIC DISC DISORDER 3 0.0143
162 RETINAL PIGMENT EPITHELIOPATHY 6 0.0139
163 DIABETIC RETINAL OEDEMA 7 0.0138
164 DERMATOCHALASIS 2 0.0136
165 DELAYED DARK ADAPTATION 1 0.0135
166 VITREOUS DETACHMENT 29 0.0134
167 INTRAOCULAR PRESSURE DECREASED 7 0.0133
168 MACULAR FIBROSIS 9 0.0133
169 RETINOPATHY HYPERTENSIVE 4 0.0132
170 VISUAL ACUITY REDUCED 435 0.0131
171 CORNEAL LESION 4 0.0130
172 CONJUNCTIVAL HYPERAEMIA 45 0.0126
173 MACULAR OEDEMA 70 0.0125
174 CORNEAL DECOMPENSATION 2 0.0124
175 CORNEAL DEGENERATION 3 0.0124
176 SCLERAL OEDEMA 1 0.0120
177 CORNEAL OEDEMA 27 0.0120
178 MACULAR THICKENING 1 0.0119
179 MACULAR CYST 1 0.0119
180 OCULAR ISCHAEMIC SYNDROME 1 0.0118
181 ACUTE MACULAR NEURORETINOPATHY 2 0.0117
182 PSEUDOPHAKIA 1 0.0115
183 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 2 0.0113
184 SCLERITIS 18 0.0112
185 ADMINISTRATION SITE INFLAMMATION 1 0.0111
186 BORDERLINE GLAUCOMA 2 0.0108
187 CORNEAL DEPOSITS 8 0.0108
188 ENDOPHTHALMITIS 64 0.0107
189 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 9 0.0105
190 MACULAR SCAR 2 0.0103
191 VIRAL UVEITIS 1 0.0103
192 ERYTHROPSIA 1 0.0102
193 HYPOAESTHESIA EYE 6 0.0102
194 CHORIORETINAL DISORDER 2 0.0102
195 CILIARY BODY DISORDER 1 0.0101
196 CORNEAL EXFOLIATION 1 0.0098
197 OCULAR HYPERTENSION 19 0.0098
198 SUBACUTE ENDOCARDITIS 1 0.0097
199 MACULAR HOLE 13 0.0097
200 DYSCHROMATOPSIA 8 0.0097
201 THROMBOANGIITIS OBLITERANS 1 0.0096
202 RETINAL DISORDER 25 0.0096
203 ARTERITIS 6 0.0095
204 PHOTOPSIA 60 0.0095
205 PINGUECULA 1 0.0094
206 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
207 VISUAL FIELD DEFECT 66 0.0091
208 CHOROIDAL DETACHMENT 5 0.0090
209 INTRAOCULAR PRESSURE INCREASED 114 0.0089
210 RETINAL ARTERY THROMBOSIS 2 0.0088
211 CHOROIDAL EFFUSION 7 0.0087
212 EPISCLERITIS 6 0.0087
213 PERSISTENT CORNEAL EPITHELIAL DEFECT 1 0.0085
214 PERIPHERAL VEIN OCCLUSION 1 0.0084
215 PUPILLARY DISORDER 5 0.0082
216 CATARACT SUBCAPSULAR 5 0.0082
217 RETINITIS 14 0.0081
218 CORNEAL OPACITY 11 0.0081
219 CYSTOID MACULAR OEDEMA 15 0.0080
220 ACETONAEMIA 2 0.0079
221 EYE HAEMORRHAGE 103 0.0077
222 EYE HAEMATOMA 2 0.0076
223 EYE COMPLICATION ASSOCIATED WITH DEVICE 2 0.0074
224 CONJUNCTIVAL IRRITATION 1 0.0074
225 RETINOSCHISIS 1 0.0072
226 EYE INJURY 22 0.0072
227 OCULAR STROKE 1 0.0072
228 HYPOTONY OF EYE 3 0.0071
229 DIABETIC GANGRENE 2 0.0070
230 LENS DISORDER 2 0.0069
231 OCULAR DISCOMFORT 78 0.0069
232 INSTILLATION SITE FOREIGN BODY SENSATION 1 0.0069
233 OPTIC ATROPHY 11 0.0067
234 CATARACT CORTICAL 1 0.0067
235 BENIGN NEOPLASM OF ADRENAL GLAND 1 0.0067
236 EYE OEDEMA 16 0.0065
237 OPEN ANGLE GLAUCOMA 4 0.0065
238 COLD-STIMULUS HEADACHE 2 0.0063
239 PAPILLOEDEMA 28 0.0062
240 OCULAR VASCULAR DISORDER 5 0.0061
241 BLINDNESS 247 0.0061
242 GIANT CELL ARTERITIS 5 0.0060
243 CORNEAL DISORDER 13 0.0059
244 READING DISORDER 13 0.0057
245 EYE PAIN 319 0.0056
246 PROCEDURAL FAILURE 1 0.0056
247 FOREIGN BODY SENSATION IN EYES 35 0.0055
248 CEREBELLAR ISCHAEMIA 1 0.0054
249 ILLOGICAL THINKING 1 0.0053
250 RETINAL TEAR 13 0.0053
251 FOREIGN BODY IN EYE 5 0.0052
252 OPHTHALMIC HERPES SIMPLEX 3 0.0052
253 RETINOPATHY PROLIFERATIVE 1 0.0051
254 ADRENOMEGALY 1 0.0048
255 RHEGMATOGENOUS RETINAL DETACHMENT 1 0.0048
256 AMAUROSIS 4 0.0048
257 OCULAR HYPERAEMIA 224 0.0047
258 NECROTISING RETINITIS 3 0.0047
259 COLONOSCOPY ABNORMAL 2 0.0047
260 VISUAL IMPAIRMENT 573 0.0046
261 KERATITIS 14 0.0046
262 SUPERFICIAL INJURY OF EYE 5 0.0046
263 THERMAL BURNS OF EYE 1 0.0044
264 SCLERAL HYPERAEMIA 3 0.0044
265 SCLERAL HAEMORRHAGE 1 0.0043
266 ENDOTHELIAL DYSFUNCTION 1 0.0043
267 PUNCTURE SITE PAIN 1 0.0043
268 INTRAOCULAR PRESSURE TEST ABNORMAL 3 0.0043
269 BLINDNESS UNILATERAL 60 0.0042
270 CANCER IN REMISSION 1 0.0041
271 MACULAR DETACHMENT 1 0.0041
272 CORNEAL NEOVASCULARISATION 1 0.0040
273 CORNEAL SCAR 2 0.0040
274 CHROMATOPSIA 3 0.0040
275 PERITONEAL ADHESIONS 1 0.0039
276 SELF-CONSCIOUSNESS 1 0.0039
277 VISION BLURRED 536 0.0039
278 RETINAL INJURY 3 0.0039
279 CONCOMITANT DISEASE AGGRAVATED 24 0.0039
280 OSCILLOPSIA 1 0.0039
281 RETINITIS PIGMENTOSA 1 0.0038
282 RETINAL VASCULAR THROMBOSIS 2 0.0038
283 RETINAL PIGMENTATION 3 0.0038
284 DEPOSIT EYE 1 0.0037
285 IRIS DISORDER 2 0.0037
286 MACULOPATHY 13 0.0037
287 SEROSITIS 2 0.0036
288 OCCIPITAL NEURALGIA 2 0.0035
289 MALIGNANT NEOPLASM OF EYE 1 0.0035
290 CORNEAL EPITHELIUM DEFECT 2 0.0034
291 LACRIMAL DISORDER 2 0.0034
292 VITRECTOMY 2 0.0034
293 PHOTOPHOBIA 63 0.0033
294 VASCULAR OCCLUSION 7 0.0033
295 EYE ABSCESS 1 0.0033
296 PUNCTATE KERATITIS 3 0.0033
297 GASTROINTESTINAL EROSION 2 0.0031
298 TYPHOID FEVER 1 0.0031
299 CONJUNCTIVAL HAEMORRHAGE 12 0.0031
300 OPTIC NERVE DISORDER 5 0.0031
301 EYE INFECTION VIRAL 1 0.0031
302 INJECTION SITE THROMBOSIS 1 0.0030
303 ABNORMAL SENSATION IN EYE 13 0.0030
304 EYE COLOUR CHANGE 3 0.0029
305 CONJUNCTIVAL OEDEMA 3 0.0029
306 VASCULAR STENOSIS 1 0.0029
307 THYMOMA 1 0.0028
308 MACULAR DEGENERATION 33 0.0028
309 COLOUR BLINDNESS ACQUIRED 1 0.0028
310 ASTHENOPIA 15 0.0027
311 LID SULCUS DEEPENED 1 0.0027
312 CHOROIDITIS 1 0.0027
313 THROMBOTIC CEREBRAL INFARCTION 1 0.0027
314 SENSATION OF BLOOD FLOW 1 0.0026
315 CAPILLARY DISORDER 1 0.0026
316 EYE INFECTION FUNGAL 1 0.0026
317 HYPERAEMIA 5 0.0025
318 TRICUSPID VALVE DISEASE 1 0.0025
319 LAGOPHTHALMOS 1 0.0024
320 GLAUCOMA 47 0.0024
321 EYE DISCHARGE 25 0.0024
322 RETINAL DETACHMENT 22 0.0024
323 TISSUE INJURY 1 0.0023
324 ALLERGY TO PLANTS 1 0.0022
325 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
326 COLOUR BLINDNESS 2 0.0022
327 VASCULITIS 25 0.0021
328 OVARIAN DISORDER 2 0.0021
329 CHORIORETINOPATHY 3 0.0021
330 HYPERMETROPIA 2 0.0021
331 CEREBRAL ARTERY STENOSIS 1 0.0020
332 DARK CIRCLES UNDER EYES 3 0.0020
333 LACRIMATION INCREASED 61 0.0020
334 BLEPHARAL PIGMENTATION 1 0.0020
335 ASTIGMATISM 3 0.0020
336 CATARACT OPERATION COMPLICATION 1 0.0020
337 ANGLE CLOSURE GLAUCOMA 5 0.0020
338 GLARE 1 0.0019
339 ABDOMINAL INJURY 1 0.0019
340 NAIL RIDGING 1 0.0019
341 EYE CONTUSION 4 0.0019
342 MYDRIASIS 24 0.0019
343 CEREBRAL ARTERY OCCLUSION 2 0.0019
344 PERIORBITAL CELLULITIS 1 0.0019
345 FRACTURE PAIN 1 0.0019
346 OPTIC ISCHAEMIC NEUROPATHY 7 0.0018
347 EYE INFECTION BACTERIAL 1 0.0018
348 INTRACRANIAL HAEMATOMA 1 0.0018
349 HALO VISION 2 0.0018
350 CELLULITIS ORBITAL 1 0.0017
351 AMBLYOPIA 1 0.0017
352 PNEUMOCOCCAL INFECTION 1 0.0017
353 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
354 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
355 CATARACT 98 0.0016
356 EYE PRURITUS 55 0.0016
357 NEURODEGENERATIVE DISORDER 1 0.0016
358 PUPILLARY REFLEX IMPAIRED 3 0.0016
359 EYELID IRRITATION 4 0.0016
360 SWELLING OF EYELID 10 0.0016
361 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
362 PERNICIOUS ANAEMIA 1 0.0016
363 MALLORY-WEISS SYNDROME 2 0.0016
364 CAROTID ARTERY DISEASE 2 0.0016
365 CHALAZION 1 0.0016
366 ATROPHY 3 0.0015
367 REFLEXES ABNORMAL 1 0.0015
368 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
369 EYE INFECTION 17 0.0015
370 BLEPHARITIS 6 0.0015
371 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
372 EFFUSION 2 0.0015
373 EYE IRRITATION 84 0.0015
374 RETINAL VEIN THROMBOSIS 1 0.0014
375 OPTIC NEURITIS 13 0.0014
376 SUTURE RELATED COMPLICATION 1 0.0014
377 VASCULITIS NECROTISING 1 0.0014
378 ORTHOSTATIC INTOLERANCE 1 0.0014
379 DYSLALIA 1 0.0014
380 BLOOD FOLATE DECREASED 1 0.0014
381 EYE DISORDER 45 0.0014
382 APRAXIA 2 0.0013
383 ARTERIAL INJURY 1 0.0013
384 SENSITISATION 1 0.0013
385 BLOOD FIBRINOGEN INCREASED 1 0.0013
386 EYELID EXFOLIATION 1 0.0013
387 KERATOPATHY 2 0.0013
388 MYOPIA 3 0.0013
389 PARATHYROID DISORDER 1 0.0012
390 FEAR OF FALLING 1 0.0012
391 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
392 RESORPTION BONE INCREASED 1 0.0012
393 ADRENAL MASS 1 0.0012
394 PERIORBITAL PAIN 1 0.0012
395 DEFORMITY 11 0.0012
396 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
397 PHYSICAL DECONDITIONING 3 0.0012
398 EYE SWELLING 43 0.0012
399 ARTERIAL STENOSIS 1 0.0011
400 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
401 ARTERIOVENOUS MALFORMATION 1 0.0011
402 ESSENTIAL HYPERTENSION 2 0.0011
403 EXTENSOR PLANTAR RESPONSE 1 0.0011
404 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
405 INJECTION SITE DISCOMFORT 11 0.0010
406 CARDIOPULMONARY FAILURE 4 0.0010
407 CONCOMITANT DISEASE PROGRESSION 2 0.0010
408 HEMIANOPIA 1 0.0010
409 EYELID PAIN 2 0.0010
410 DRY EYE 49 0.0010
411 BRAIN STEM INFARCTION 1 0.0010
412 URETEROLITHIASIS 1 0.0010
413 HYPOPERFUSION 1 0.0010
414 OPTIC NEUROPATHY 2 0.0009
415 AMAUROSIS FUGAX 1 0.0009
416 LANGUAGE DISORDER 2 0.0009
417 TOXIC ANTERIOR SEGMENT SYNDROME 1 0.0009
418 DIABETIC NEPHROPATHY 2 0.0009
419 PERIORBITAL SWELLING 5 0.0009
420 VITH NERVE PARALYSIS 1 0.0009
421 HYPERTONIA 5 0.0009
422 ADMINISTRATION SITE PAIN 1 0.0009
423 LICHEN PLANUS 2 0.0009
424 OPTIC NERVE INJURY 1 0.0009
425 HYPERREFLEXIA 3 0.0009
426 UTERINE DISORDER 2 0.0009
427 FEBRILE INFECTION 1 0.0008
428 BILE DUCT CANCER 1 0.0008
429 MULTIMORBIDITY 1 0.0008
430 BRONCHITIS CHRONIC 2 0.0008
431 CONJUNCTIVITIS 15 0.0008
432 FRACTURED SACRUM 1 0.0008
433 HEPATIC INFECTION 1 0.0008
434 HERPES OPHTHALMIC 1 0.0008
435 EXTRADURAL HAEMATOMA 1 0.0008
436 ERYTHEMA OF EYELID 4 0.0007
437 ULCERATIVE KERATITIS 2 0.0007
438 CORNEAL ABRASION 1 0.0007
439 RENAL ARTERY STENOSIS 1 0.0007
440 RED BLOOD CELL COUNT INCREASED 2 0.0007
441 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
442 PERIPHERAL ARTERY OCCLUSION 1 0.0007
443 INTESTINAL FISTULA 1 0.0007
444 AORTIC VALVE INCOMPETENCE 3 0.0007
445 INJECTION SITE HYPOAESTHESIA 1 0.0007
446 NONINFECTIVE GINGIVITIS 1 0.0007
447 ANKLE OPERATION 1 0.0007
448 CONJUNCTIVITIS ALLERGIC 1 0.0007
449 HYPOACUSIS 29 0.0007
450 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
451 MANTLE CELL LYMPHOMA 1 0.0007
452 EAR DISORDER 3 0.0007
453 MEAN CELL VOLUME DECREASED 1 0.0006
454 EYE ALLERGY 1 0.0006
455 VASCULAR RUPTURE 1 0.0006
456 OPHTHALMOPLEGIA 1 0.0006
457 PHARYNGEAL PARAESTHESIA 1 0.0006
458 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
459 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
460 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
461 DIABETIC RETINOPATHY 2 0.0006
462 EXPOSURE TO SARS-COV-2 1 0.0006
463 AMYLOIDOSIS 1 0.0006
464 CEREBRAL INFARCTION 14 0.0006
465 EMBOLIC STROKE 2 0.0006
466 MONOPARESIS 1 0.0006
467 INJECTION SITE INJURY 3 0.0005
468 ACCIDENTAL DEATH 1 0.0005
469 HYPERTENSIVE HEART DISEASE 1 0.0005
470 DISEASE PROGRESSION 62 0.0005
471 TRAUMATIC LUNG INJURY 1 0.0005
472 PELVIC FRACTURE 4 0.0005
473 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
474 DISEASE RECURRENCE 24 0.0005
475 FRUSTRATION TOLERANCE DECREASED 4 0.0005
476 PERIPHERAL ISCHAEMIA 2 0.0005
477 HEMIPLEGIA 4 0.0005
478 SELF-INJURIOUS IDEATION 2 0.0005
479 DEVICE CONNECTION ISSUE 1 0.0005
480 NEUROGENIC BLADDER 1 0.0005
481 SLEEP DEFICIT 1 0.0005
482 HORDEOLUM 2 0.0005
483 DIPLOPIA 12 0.0005
484 UPPER LIMB FRACTURE 9 0.0005
485 GASTROINTESTINAL ULCER 1 0.0005
486 ISCHAEMIC STROKE 8 0.0004
487 INFLAMMATION 23 0.0004
488 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
489 RENAL COLIC 1 0.0004
490 IMPAIRED DRIVING ABILITY 5 0.0004
491 EYELID DISORDER 1 0.0004
492 HAEMANGIOMA 1 0.0004
493 DISCOURAGEMENT 1 0.0004
494 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
495 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
496 ANHEDONIA 11 0.0004
497 PANNICULITIS 1 0.0004
498 INJECTION SITE INFLAMMATION 2 0.0004
499 VEIN DISORDER 2 0.0004
500 PRODUCT USE IN UNAPPROVED INDICATION 99 0.0004
501 CORONARY ARTERY STENOSIS 2 0.0004
502 VASODILATATION 1 0.0004
503 AORTIC ANEURYSM 3 0.0004
504 DIABETIC COMPLICATION 1 0.0004
505 SEDATION COMPLICATION 1 0.0004
506 NOCARDIOSIS 1 0.0004
507 PHLEBITIS 2 0.0004
508 NASAL DISORDER 1 0.0004
509 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
510 THERAPEUTIC RESPONSE DELAYED 1 0.0004
511 ACUTE PULMONARY OEDEMA 2 0.0004
512 SKIN HYPERTROPHY 1 0.0004
513 EYELID MARGIN CRUSTING 1 0.0003
514 EYELID OEDEMA 4 0.0003
515 STRABISMUS 1 0.0003
516 ILLNESS 35 0.0003
517 SYMPTOM RECURRENCE 2 0.0003
518 OROPHARYNGEAL DISCOMFORT 3 0.0003
519 CEREBROVASCULAR DISORDER 1 0.0003
520 EMBOLISM VENOUS 1 0.0003
521 FIBROSIS 1 0.0003
522 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
523 PRE-EXISTING CONDITION IMPROVED 2 0.0003
524 ARTERIOSCLEROSIS 3 0.0003
525 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
526 LYMPHOCYTE COUNT INCREASED 1 0.0003
527 DEAFNESS NEUROSENSORY 1 0.0003
528 DYSGRAPHIA 2 0.0003
529 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
530 DRY THROAT 3 0.0003
531 INFARCTION 2 0.0003
532 DEMENTIA 8 0.0003
533 PRODUCT STORAGE ERROR 25 0.0003
534 BONE EROSION 1 0.0003
535 HEAD DISCOMFORT 5 0.0003
536 HAND FRACTURE 2 0.0003
537 DIVERTICULUM 2 0.0003
538 PRODUCT CONTAMINATION 1 0.0003
539 SPONDYLITIS 1 0.0003
540 DEAFNESS 7 0.0003
541 HYDRONEPHROSIS 2 0.0003
542 CHRONIC SINUSITIS 1 0.0003
543 PROTEIN TOTAL DECREASED 1 0.0003
544 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
545 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
546 HAEMORRHAGIC STROKE 2 0.0003
547 CERVIX CARCINOMA 1 0.0003
548 PROCEDURAL HAEMORRHAGE 1 0.0003
549 VENOUS THROMBOSIS 1 0.0003
550 POLYDIPSIA 1 0.0003
551 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
552 CEREBRAL HAEMORRHAGE 9 0.0003
553 HYPERURICAEMIA 1 0.0002
554 INJECTION SITE EXTRAVASATION 3 0.0002
555 SPINAL STENOSIS 1 0.0002
556 AORTIC DISSECTION 1 0.0002
557 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
558 THROAT CANCER 1 0.0002
559 INJECTION SITE IRRITATION 3 0.0002
560 CARDIAC FAILURE CHRONIC 1 0.0002
561 DEATH 202 0.0002
562 PRODUCT USE ISSUE 44 0.0002
563 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
564 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
565 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
566 RHINITIS ALLERGIC 1 0.0002
567 FACIAL PAIN 2 0.0002
568 BRAIN NEOPLASM MALIGNANT 1 0.0002
569 SNEEZING 5 0.0002
570 SUSPECTED OFF LABEL USE 1 0.0002
571 HAEMOGLOBIN INCREASED 1 0.0002
572 ISCHAEMIA 1 0.0002
573 RHINORRHOEA 14 0.0002
574 ARTHRITIS INFECTIVE 1 0.0002
575 UMBILICAL HERNIA 1 0.0002
576 CEREBROVASCULAR ACCIDENT 36 0.0002
577 COLITIS MICROSCOPIC 1 0.0002
578 MEMORY IMPAIRMENT 29 0.0002
579 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
580 NERVOUSNESS 11 0.0002
581 SARCOIDOSIS 1 0.0002
582 AUTOIMMUNE DISORDER 2 0.0002
583 INFLAMMATORY MARKER INCREASED 1 0.0002
584 BLOOD PRESSURE ABNORMAL 4 0.0002
585 ANEURYSM 1 0.0002
586 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
587 TOOTH ABSCESS 2 0.0002
588 BODY TEMPERATURE INCREASED 4 0.0002
589 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
590 PRODUCT COLOUR ISSUE 1 0.0002
591 PERIPHERAL VASCULAR DISORDER 1 0.0002
592 TEMPERATURE INTOLERANCE 2 0.0002
593 TRISMUS 1 0.0002
594 PERIORBITAL OEDEMA 1 0.0002
595 TONSILLITIS 1 0.0002
596 HALLUCINATION, VISUAL 4 0.0002
597 COMPRESSION FRACTURE 1 0.0002
598 HIP FRACTURE 6 0.0002
599 OVERWEIGHT 1 0.0002
600 PRODUCT RESIDUE PRESENT 1 0.0002
601 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
602 THERAPEUTIC RESPONSE DECREASED 11 0.0002
603 STREPTOCOCCAL INFECTION 1 0.0002
604 HEART RATE ABNORMAL 1 0.0002
605 ANGIOPATHY 1 0.0002
606 COUGH 50 0.0002
607 PRODUCT LEAKAGE 1 0.0002
608 OFF LABEL USE 151 0.0002
609 MADAROSIS 2 0.0002
610 COVID-19 PNEUMONIA 2 0.0002
611 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
612 CATARACT OPERATION 1 0.0002
613 DRUG INEFFECTIVE 221 0.0002
614 POLYNEUROPATHY 2 0.0002
615 WRIST FRACTURE 2 0.0002
616 BLOOD PRESSURE FLUCTUATION 4 0.0002
617 GANGRENE 1 0.0002
618 TENSION 1 0.0002
619 VERTIGO 10 0.0002
620 BRONCHITIS 12 0.0002
621 INJECTION SITE DISCOLOURATION 2 0.0002
622 SECRETION DISCHARGE 2 0.0002
623 NASAL DRYNESS 1 0.0002
624 BLEPHAROSPASM 1 0.0002
625 HAEMATEMESIS 4 0.0002
626 THERAPY NON-RESPONDER 7 0.0002
627 EAR PAIN 3 0.0002
628 HERPES SIMPLEX 1 0.0002
629 HAEMORRHAGE 16 0.0002
630 POLYP 1 0.0002
631 IMMUNE SYSTEM DISORDER 2 0.0002
632 CONDITION AGGRAVATED 46 0.0002
633 CORONAVIRUS INFECTION 1 0.0002
634 FEAR 4 0.0001
635 COVID-19 26 0.0001
636 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
637 EYE MOVEMENT DISORDER 1 0.0001
638 ONYCHOCLASIS 1 0.0001
639 AUTOIMMUNE HEPATITIS 1 0.0001
640 APHONIA 2 0.0001
641 MASS 2 0.0001
642 SKIN REACTION 2 0.0001
643 THERMAL BURN 1 0.0001
644 PARALYSIS 2 0.0001
645 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
646 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
647 PRODUCT PRESCRIBING ISSUE 3 0.0001
648 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
649 PRODUCT DOSE OMISSION ISSUE 40 0.0001
650 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
651 RASH MACULO-PAPULAR 3 0.0001
652 COLON CANCER 2 0.0001
653 ABDOMINAL DISCOMFORT 22 0.0001
654 DISCOMFORT 8 0.0001
655 PROCEDURAL COMPLICATION 1 0.0001
656 THYROID DISORDER 2 0.0001
657 FOOD ALLERGY 1 0.0001
658 HAEMOLYSIS 1 0.0001
659 BLOOD ALBUMIN DECREASED 1 0.0001
660 CYSTITIS 4 0.0001
661 SCIATICA 2 0.0001
662 ATRIAL FLUTTER 1 0.0001
663 THROMBOSIS 10 0.0001
664 BLOOD PRESSURE INCREASED 19 0.0001
665 RHINITIS 1 0.0001
666 INJECTION SITE PAIN 38 0.0001
667 MUSCLE DISORDER 1 0.0001
668 POLYURIA 1 0.0001
669 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
670 PHOTOSENSITIVITY REACTION 2 0.0001
671 SPINAL COMPRESSION FRACTURE 1 0.0001
672 MYOCARDIAL INFARCTION 21 0.0001
673 DIABETES MELLITUS 9 0.0001
674 CIRCULATORY COLLAPSE 2 0.0001
675 SINUSITIS 12 0.0001
676 SCAR 2 0.0001
677 MUSCLE STRAIN 1 0.0001
678 BLOOD CALCIUM INCREASED 1 0.0001
679 PRODUCT COMMUNICATION ISSUE 1 0.0001
680 MALAISE 49 0.0001
681 GASTROINTESTINAL INFECTION 1 0.0001
682 GASTROINTESTINAL CARCINOMA 1 0.0001
683 BRAIN NEOPLASM 1 0.0001
684 NERVE COMPRESSION 1 0.0001
685 EMOTIONAL DISTRESS 13 0.0001
686 NEPHROPATHY 1 0.0001
687 FLANK PAIN 1 0.0001
688 HEPATIC CIRRHOSIS 2 0.0001
689 DYSARTHRIA 4 0.0001
690 BLOOD SODIUM DECREASED 2 0.0001
691 FALL 35 0.0001
692 NO ADVERSE EVENT 19 0.0001
693 FEELING ABNORMAL 25 0.0001
694 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
695 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
696 KIDNEY INFECTION 2 0.0001
697 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
698 ARTHRITIS 8 0.0001
699 PSYCHOTIC DISORDER 3 0.0001
700 URINARY INCONTINENCE 3 0.0001
701 SINUS DISORDER 2 0.0001
702 HAEMATOCRIT DECREASED 2 0.0001
703 BLADDER DISORDER 1 0.0001
704 SPINAL FRACTURE 2 0.0001
705 INJURY 7 0.0001
706 HYPERTENSION 21 0.0001
707 PRODUCT ADMINISTRATION ERROR 2 0.0001
708 EYELID PTOSIS 1 0.0001
709 INJURY ASSOCIATED WITH DEVICE 2 0.0001
710 SUBARACHNOID HAEMORRHAGE 1 0.0001
711 NEUTROPHIL COUNT INCREASED 1 0.0001
712 PRODUCT PREPARATION ERROR 2 0.0001
713 LUNG NEOPLASM MALIGNANT 4 0.0001
714 HEADACHE 59 0.0001
715 ATRIAL FIBRILLATION 9 0.0001
716 OESOPHAGITIS 1 0.0001
717 BLOOD GLUCOSE FLUCTUATION 1 0.0001
718 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
719 TOOTH FRACTURE 1 0.0001
720 HYPERTENSIVE CRISIS 1 0.0001
721 INTESTINAL PERFORATION 1 0.0001
722 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
723 MITRAL VALVE INCOMPETENCE 1 0.0001
724 PRODUCT AVAILABILITY ISSUE 2 0.0001
725 INTERNAL HAEMORRHAGE 1 0.0001
726 GASTRIC DISORDER 3 0.0001
727 METASTASES TO LUNG 1 0.0001
728 DELIRIUM 3 0.0001
729 SPINAL PAIN 1 0.0001
730 ANXIETY 24 0.0001
731 ILL-DEFINED DISORDER 5 0.0001
732 NASOPHARYNGITIS 15 0.0001
733 EPISTAXIS 6 0.0001
734 DERMATITIS ALLERGIC 1 0.0001
735 FLUID RETENTION 4 0.0001
736 RESPIRATORY TRACT INFECTION 2 0.0001
737 PLATELET COUNT INCREASED 1 0.0001
738 PRODUCT DOSE OMISSION 5 0.0001
739 SPEECH DISORDER 4 0.0001
740 ANKYLOSING SPONDYLITIS 1 0.0001
741 PULMONARY CONGESTION 1 0.0001
742 DISORIENTATION 3 0.0001
743 INJECTION SITE HAEMORRHAGE 6 0.0001
744 MALIGNANT MELANOMA 1 0.0001
745 QUALITY OF LIFE DECREASED 1 0.0001
746 PAIN 45 0.0001
747 GINGIVAL BLEEDING 1 0.0001
748 GAIT DISTURBANCE 14 0.0001
749 CORONARY ARTERY OCCLUSION 1 0.0001
750 SKIN LESION 2 0.0001
751 TREATMENT FAILURE 6 0.0001
752 PYREXIA 25 0.0001
753 ORAL DISCOMFORT 1 0.0001
754 ROAD TRAFFIC ACCIDENT 3 0.0001
755 BLOOD TEST ABNORMAL 1 0.0001
756 SEASONAL ALLERGY 1 0.0001
757 BRONCHOSPASM 1 0.0001
758 HERPES ZOSTER 4 0.0001
759 PARAESTHESIA ORAL 1 0.0001
760 PANCREATIC CARCINOMA 2 0.0001
761 INFECTION 10 0.0001
762 ANOSMIA 1 0.0001
763 HYPOKINESIA 1 0.0001
764 NEEDLE ISSUE 2 0.0001
765 GASTROENTERITIS 1 0.0001
766 DYSSTASIA 2 0.0001
767 DYSPHONIA 4 0.0001
768 ACUTE MYOCARDIAL INFARCTION 2 0.0001
769 PULMONARY MASS 1 0.0001
770 HYPOAESTHESIA 10 0.0001
771 APHASIA 2 0.0001
772 CORONARY ARTERY DISEASE 2 0.0001
773 SKIN DISCOLOURATION 3 0.0001
774 EMOTIONAL DISORDER 2 0.0001
775 MUSCULOSKELETAL CHEST PAIN 1 0.0001
776 ANKLE FRACTURE 1 0.0001
777 TENDONITIS 1 0.0001
778 RENAL DISORDER 3 0.0001
779 EJECTION FRACTION DECREASED 1 0.0001
780 COGNITIVE DISORDER 3 0.0001
781 HEAD INJURY 2 0.0001
782 PNEUMOTHORAX 1 0.0001
783 LOSS OF CONSCIOUSNESS 8 0.0001
784 SENSORY DISTURBANCE 1 0.0001
785 BACK DISORDER 1 0.0001
786 LUNG DISORDER 3 0.0001
787 CHOLELITHIASIS 2 0.0001
788 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
789 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
790 COAGULOPATHY 1 0.0001
791 URINARY RETENTION 2 0.0001
792 NEOPLASM MALIGNANT 4 0.0001
793 BLOOD UREA INCREASED 1 0.0001
794 CELLULITIS 3 0.0001
795 HEMIPARESIS 1 0.0001
796 HAEMATURIA 2 0.0001
797 BLOOD GLUCOSE INCREASED 11 0.0001
798 ERYTHEMA 12 0.0001
799 MUSCULOSKELETAL DISCOMFORT 1 0.0001
800 BALANCE DISORDER 5 0.0001
801 DEPRESSED MOOD 3 0.0001
802 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
803 CONFUSIONAL STATE 9 0.0001
804 CRYING 2 0.0001
805 HYPERGLYCAEMIA 2 0.0001
806 RESTLESSNESS 2 0.0001
807 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
808 HYPERSENSITIVITY 10 0.0001
809 THINKING ABNORMAL 1 0.0001
810 MIDDLE INSOMNIA 1 0.0001
811 FOOT FRACTURE 1 0.0001
812 BLOOD URINE PRESENT 1 0.0001
813 INCORRECT DOSE ADMINISTERED 12 0.0001
814 FEELING JITTERY 1 0.0001
815 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
816 HAEMORRHOIDS 1 0.0001
817 ORAL HERPES 1 0.0001
818 SKIN FISSURES 1 0.0001
819 CARDIAC FAILURE 4 0.0000
820 PRODUCT PHYSICAL ISSUE 1 0.0000
821 INSOMNIA 13 0.0000
822 RIB FRACTURE 1 0.0000
823 URTICARIA 8 0.0000
824 JOINT INJURY 1 0.0000
825 AMNESIA 3 0.0000
826 SWELLING FACE 3 0.0000
827 MENTAL DISORDER 2 0.0000
828 MUSCULOSKELETAL STIFFNESS 4 0.0000
829 MELAENA 1 0.0000
830 APPLICATION SITE PAIN 1 0.0000
831 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
832 STEVENS-JOHNSON SYNDROME 1 0.0000
833 SOMNOLENCE 9 0.0000
834 HEART RATE IRREGULAR 1 0.0000
835 MUSCULAR WEAKNESS 5 0.0000
836 TINNITUS 2 0.0000
837 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
838 OROPHARYNGEAL PAIN 4 0.0000
839 CHEST PAIN 8 0.0000
840 BLOOD CHOLESTEROL INCREASED 2 0.0000
841 CARDIAC DISORDER 4 0.0000
842 DEVICE MALFUNCTION 3 0.0000
843 PRODUCT PRESCRIBING ERROR 1 0.0000
844 MIGRAINE 4 0.0000
845 PRODUCTIVE COUGH 2 0.0000
846 MOBILITY DECREASED 3 0.0000
847 HEPATIC CANCER 1 0.0000
848 CONTUSION 4 0.0000
849 MENTAL IMPAIRMENT 1 0.0000
850 FIBROMYALGIA 1 0.0000
851 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
852 PNEUMONIA 13 0.0000
853 AGEUSIA 1 0.0000
854 SYNCOPE 4 0.0000
855 FATIGUE 31 0.0000
856 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
857 ABDOMINAL PAIN LOWER 1 0.0000
858 CHRONIC KIDNEY DISEASE 3 0.0000
859 WEIGHT DECREASED 11 0.0000
860 CARDIOVASCULAR DISORDER 1 0.0000
861 HYPOPHAGIA 1 0.0000
862 PRURITUS 15 0.0000
863 DRUG RESISTANCE 1 0.0000
864 ANAPHYLACTIC SHOCK 1 0.0000
865 EXPOSURE VIA SKIN CONTACT 1 0.0000
866 EAR INFECTION 1 0.0000
867 DISTURBANCE IN ATTENTION 2 0.0000
868 THROAT TIGHTNESS 1 0.0000
869 CARDIAC ARREST 3 0.0000
870 PROCEDURAL PAIN 1 0.0000
871 INFLUENZA 4 0.0000
872 HAEMOPTYSIS 1 0.0000
873 RENAL IMPAIRMENT 3 0.0000
874 BLISTER 2 0.0000
875 ASTHMA 4 0.0000
876 RED BLOOD CELL COUNT DECREASED 1 0.0000
877 ANGINA PECTORIS 1 0.0000
878 HYPERSOMNIA 1 0.0000
879 WHEEZING 2 0.0000
880 BLOOD POTASSIUM DECREASED 1 0.0000
881 LIMB DISCOMFORT 1 0.0000
882 BREAST CANCER 3 0.0000
883 SWELLING 3 0.0000
884 NERVOUS SYSTEM DISORDER 1 0.0000
885 ASTHENIA 12 0.0000
886 MOVEMENT DISORDER 1 0.0000
887 DEEP VEIN THROMBOSIS 2 0.0000
888 BLOOD CREATININE INCREASED 2 0.0000
889 ALOPECIA 6 0.0000
890 STAPHYLOCOCCAL INFECTION 1 0.0000
891 BACK PAIN 7 0.0000
892 DEHYDRATION 4 0.0000
893 SKIN DISORDER 1 0.0000
894 GAIT INABILITY 1 0.0000
895 RASH MACULAR 1 0.0000
896 HEART RATE DECREASED 1 0.0000
897 HYPOXIA 1 0.0000
898 SLEEP DISORDER 2 0.0000
899 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
900 DIZZINESS 14 0.0000
901 C-REACTIVE PROTEIN INCREASED 1 0.0000
902 RESPIRATORY FAILURE 2 0.0000
903 DYSPNOEA EXERTIONAL 1 0.0000
904 UNEVALUABLE EVENT 2 0.0000
905 RHEUMATOID ARTHRITIS 3 0.0000
906 COLITIS 1 0.0000
907 INJECTION SITE SWELLING 2 0.0000
908 PLASMA CELL MYELOMA 1 0.0000
909 HYPOTENSION 5 0.0000
910 CARDIAC FAILURE CONGESTIVE 2 0.0000
911 PROSTATE CANCER 2 0.0000
912 JOINT SWELLING 3 0.0000
913 DRY MOUTH 2 0.0000
914 DEVICE BREAKAGE 1 0.0000
915 INFLUENZA LIKE ILLNESS 2 0.0000
916 ABDOMINAL PAIN UPPER 5 0.0000
917 ARTHRALGIA 10 0.0000
918 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
919 CARDIO-RESPIRATORY ARREST 1 0.0000
920 OSTEOARTHRITIS 1 0.0000
921 RECTAL HAEMORRHAGE 1 0.0000
922 SEPTIC SHOCK 1 0.0000
923 RENAL FAILURE 3 0.0000
924 TACHYCARDIA 2 0.0000
925 DRY SKIN 3 0.0000
926 PULMONARY OEDEMA 1 0.0000
927 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
928 NEPHROLITHIASIS 1 0.0000
929 ARRHYTHMIA 1 0.0000
930 PULMONARY EMBOLISM 2 0.0000
931 MULTIPLE SCLEROSIS 1 0.0000
932 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
933 RASH 9 0.0000
934 HEART RATE INCREASED 2 0.0000
935 LEUKOPENIA 1 0.0000
936 AGGRESSION 1 0.0000
937 CHEST DISCOMFORT 2 0.0000
938 HAEMOGLOBIN DECREASED 2 0.0000
939 PERIPHERAL SWELLING 3 0.0000
940 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
941 VOMITING 9 0.0000
942 PARAESTHESIA 3 0.0000
943 RASH PRURITIC 1 0.0000
944 OEDEMA 1 0.0000
945 CONSTIPATION 4 0.0000
946 ARTHROPATHY 1 0.0000
947 NECK PAIN 1 0.0000
948 OXYGEN SATURATION DECREASED 1 0.0000
949 URINARY TRACT INFECTION 3 0.0000
950 LETHARGY 1 0.0000
951 DECREASED APPETITE 4 0.0000
952 ABDOMINAL PAIN 4 0.0000
953 BONE PAIN 1 0.0000
954 CHILLS 2 0.0000
955 DIARRHOEA 11 0.0000
956 PAIN IN EXTREMITY 5 0.0000
957 OEDEMA PERIPHERAL 2 0.0000
958 INJECTION SITE ERYTHEMA 2 0.0000
959 ANAEMIA 3 0.0000
960 NAUSEA 12 0.0000
961 INJECTION SITE PRURITUS 1 0.0000
962 PRODUCT QUALITY ISSUE 2 0.0000
963 HEPATIC ENZYME INCREASED 1 0.0000
964 INJECTION SITE REACTION 1 0.0000
965 BURNING SENSATION 1 0.0000
966 THERAPY INTERRUPTED 1 0.0000
967 DEPRESSION 3 0.0000
968 DRUG DOSE OMISSION BY DEVICE 1 0.0000
969 INJECTION SITE BRUISING 1 0.0000
970 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
971 DYSPNOEA 7 0.0000
972 COMPLETED SUICIDE 1 0.0000
973 INTENTIONAL PRODUCT MISUSE 1 0.0000
974 GASTROINTESTINAL DISORDER 1 0.0000
975 ADVERSE DRUG REACTION 1 0.0000
976 SUICIDAL IDEATION 1 0.0000
977 MUSCLE SPASMS 2 0.0000
978 ADVERSE EVENT 1 0.0000
979 DYSPHAGIA 1 0.0000
980 NEUROPATHY PERIPHERAL 1 0.0000
981 DRUG INTOLERANCE 1 0.0000
982 PLATELET COUNT DECREASED 1 0.0000
983 SEPSIS 1 0.0000
984 WEIGHT INCREASED 2 0.0000
985 SEIZURE 1 0.0000
986 HYPERHIDROSIS 1 0.0000
987 PSORIASIS 1 0.0000
988 ACUTE KIDNEY INJURY 1 0.0000
989 TREMOR 1 0.0000